Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.
机构:[1]State Key Laboratory of Biotherapy,West China Hospital, West China Medical School, Sichuan University, Chengdu, China四川大学华西医院[2]Institute of Burn Research, Southwest Hospital, State Key laboratory of Trauma, Burns & Combined Injury, Third Military Medical University, Chongqing, China[3]The First People's Hospital of Ji'an City, Jiangxi, China
National Key Programs of China
during the 12th Five-Year Plan period (grant 2012ZX09101103-017).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类|3 区医学
小类|3 区药学4 区免疫学
最新[2023]版:
大类|2 区医学
小类|2 区免疫学2 区药学
第一作者:
第一作者机构:[1]State Key Laboratory of Biotherapy,West China Hospital, West China Medical School, Sichuan University, Chengdu, China
共同第一作者:
通讯作者:
通讯机构:[1]State Key Laboratory of Biotherapy,West China Hospital, West China Medical School, Sichuan University, Chengdu, China[*1]State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Keyuan Road 4, Gaopeng Street, Chengdu, 610041, China
推荐引用方式(GB/T 7714):
Xie Caifeng,Jingjing Wang,Li Xiaolu,et al.Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.[J].International immunopharmacology.2014,21(2):261-8.doi:10.1016/j.intimp.2014.05.012.
APA:
Xie Caifeng,Jingjing Wang,Li Xiaolu,Zeng Fei,Ma Liang...&Chen Lijuan.(2014).Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages..International immunopharmacology,21,(2)
MLA:
Xie Caifeng,et al."Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.".International immunopharmacology 21..2(2014):261-8